Connect Sign In
Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness of labs and the CDC’s proactive approach during a media briefing.
Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are essential for the diagnosis of VEXAS syndrome and concurrent hematologic neoplasms.
This edition features interviews with company leaders describing ARUP’s approaches to comply with the FDA’s rule and a video about how ARUP helped a family on a rare disease diagnostic journey.
Ryan Nelson, PharmD, received a Double Helix Award for his work on MetaCensus during the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Annual Meeting and Consensus Workshop.
Laboratory tests, including those for fluid biomarkers, may be used to diagnose Alzheimer's disease. ARUP Consult details using such tests to help clinicians order the right test at the right time.
The University of Utah Licensing and Technology Office awards recognize impactful research and innovation. Though retired, Wittwer is active in advancing molecular diagnostics and mentoring others.
ARUP Laboratories is partnering with Augurex Life Sciences Corp. to include the 14-3-3η test in the ARUP test menu to enhance the early detection of rheumatoid arthritis.
ARUP wins award for providing employees bike-friendly amenities, including a secure bike storage facility and charging stations for ebikes, as well as showers and changing rooms for use after a ride.
Updated ARUP Consult® resources on hematologic malignancies describe how laboratory tests can be used in the diagnosis, prognosis, treatment, and management of these diseases.
A new ARUP Consult® topic on testing for preeclampsia, which can be difficult to diagnose, distills guidelines from several sources to help clinicians order the right test at the right time.
